Study of Sacituzumab Govitecan in Patients With Solid Tumor
NCT05119907 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53
Last updated 2025-11-17
Summary
The goal of this study is to see how effective the study drug, sacituzumab govitecan-hziy, is in participants with solid tumor.
Conditions
Interventions
- DRUG
-
Administered intravenously
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Gilead Study Director · Gilead Sciences
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-12
- Primary Completion
- 2026-10-31
- Completion
- 2026-10-31
Countries
- China
Study Locations
More Related Trials
-
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors
NCT05194709 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of ZG005 in Patients With Advanced Solid Tumors
NCT06927687 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors
NCT03692520 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459 ·Status: RECRUITING ·Phase: PHASE1
-
An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors
NCT06076291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
NCT03744208 ·Status: UNKNOWN ·Phase: PHASE2
-
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
NCT04412616 ·Status: RECRUITING ·Phase: PHASE1
-
Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors
NCT05238818 ·Status: UNKNOWN ·Phase: PHASE1
-
U87 CART in Treatment of Advanced Solid Tumor
NCT05605197 ·Status: RECRUITING ·Phase: PHASE1
-
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
NCT05101070 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
NCT05044897 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of ZGGS34 in Participants With Advanced Solid Tumors
NCT07258121 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.
NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC
NCT05054439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor
NCT04013048 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
NCT03713372 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors
NCT05116709 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma
NCT05126719 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921 ·Status: RECRUITING ·Phase: PHASE1
-
Study of CM518D1 in Patients With Advanced Solid Tumors
NCT07019779 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
NCT05940116 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors
NCT06220318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
NCT05805956 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
NCT05990452 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
NCT05039931 ·Status: WITHDRAWN ·Phase: PHASE1